JDA is now accepting submissions!

JDA, Informa Healthcare's first open-access journal, will rapidly publish a variety of study types and opinion pieces from a range of therapeutic areas.

Unique in focus, JDA will publish smaller and lesser-impact studies, early trial data, confirmatory, incomplete/inconclusive or controversial trial results, and updates to previous research.

JDA has been created to provide a channel for reliable sound research from Phase I-IV trials, without concern as to the nature of the study results. To find out more about the aims and scope of the journal, please click here.

JDA offers:

• Open access status for all papers
• Priority publication: 5-7 weeks from submission to publication in a fully citable format
• Rigorous peer review
• Coverage of all phases of pharmaceutical development
• Full search functionality
• Ethical publication standards

JDA is the newest addition to the Current Medican Research & Opinion (CMRO) series of journals, which also includes the Journal of Medical Economics (JME).